Home Data Calendar Blog

ANVS

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Weighted Average Number Of Diluted Shares Outstanding 9.018.958.19NA8.168.168.16NA8.107.376.92NA6.87NANANA
Weighted Average Number Of Shares Outstanding Basic 9.018.958.19NA8.168.168.16NA8.107.376.92NA6.87NANANA
Earnings Per Share Basic -1.63-1.07-1.19-0.38-0.93-1.07-0.72-0.75-0.35-0.34-0.46-0.26-0.15NANANA
Earnings Per Share Diluted -1.63-1.07-1.19-0.38-0.93-1.07-0.72-0.75-0.35-0.34-0.46-0.26-0.15NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Operating Expenses 14.869.769.973.177.678.755.915.922.852.533.231.911.602.540.580.87
Research And Development Expense 13.848.267.791.585.316.822.812.881.381.822.391.410.720.860.070.76
General And Administrative Expense 1.031.502.181.592.361.943.103.041.470.710.840.500.881.690.520.11
Operating Income Loss -14.86-9.76-9.97-3.17-7.67-8.75-5.91-5.92-2.85-2.53-3.23-1.91-1.60-2.54-0.58-0.87
Interest Income Expense Nonoperating Net 0.150.220.230.070.050.040.020.010.010.000.000.000.010.030.01-0.01
Allocated Share Based Compensation Expense 0.631.571.54NA2.361.903.43NA0.79NANANANANANANA
Profit Loss -14.72-9.54-9.74-3.09-7.62-8.72-5.89-5.91-2.85-2.52-3.20-1.70-1.01-2.31-0.44-0.20
Net Income Loss -14.72-9.54-9.74-3.09-7.62-8.72-5.89-5.91-2.85-2.52-3.20-1.70-1.01-2.31-0.44-0.20

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Assets 10.2222.8225.5536.0232.4936.5343.3046.0047.6549.505.968.129.4010.2011.441.12
Liabilities 3.562.075.417.702.531.301.261.511.120.881.600.580.280.700.752.62
Liabilities And Stockholders Equity 10.2222.8225.5536.0232.4936.5343.3046.0047.6549.505.968.129.4010.2011.441.12
Stockholders Equity 6.6620.7420.1428.3229.9635.2342.0444.4946.5348.614.377.549.129.5010.69-8.58

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Assets Current 10.2222.8225.5536.0232.4936.5343.3046.0047.6549.505.968.129.4010.2011.440.75
Cash And Cash Equivalents At Carrying Value 6.3515.7216.7628.3831.9935.9742.6745.6947.4649.225.608.078.849.7611.120.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6.3515.7216.7628.3831.9935.9742.6745.6947.4649.225.608.078.849.7611.120.00

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Liabilities Current 3.562.075.417.702.531.301.261.511.120.881.600.580.280.700.752.01
Accounts Payable Current 1.931.174.153.961.850.900.930.690.290.110.820.340.140.120.051.23

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Stockholders Equity 6.6620.7420.1428.3229.9635.2342.0444.4946.5348.614.377.549.129.5010.69-8.58
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Additional Paid In Capital 94.7094.0783.9382.3880.9278.5676.6673.2269.3468.5721.8121.7821.6521.0319.910.20
Retained Earnings Accumulated Deficit -88.05-73.33-63.79-54.05-50.96-43.34-34.62-28.73-22.81-19.96-17.44-14.24-12.53-11.53-9.22-8.78
Stock Issued During Period Value New Issues NA8.57NANANANANANANA46.67NANANANA11.96NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Net Cash Provided By Used In Operating Activities -9.37-9.61-11.63-3.61-3.99-6.69-3.02-1.77-1.74-3.14-2.47-0.77-0.92-1.31-0.97-0.05
Net Cash Provided By Used In Financing Activities 0.008.570.010.000.000.000.000.00-0.0346.770.000.000.00-0.0512.09-0.00

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Net Cash Provided By Used In Operating Activities -9.37-9.61-11.63-3.61-3.99-6.69-3.02-1.77-1.74-3.14-2.47-0.77-0.92-1.31-0.97-0.05
Net Income Loss -14.72-9.54-9.74-3.09-7.62-8.72-5.89-5.91-2.85-2.52-3.20-1.70-1.01-2.31-0.44-0.20
Profit Loss -14.72-9.54-9.74-3.09-7.62-8.72-5.89-5.91-2.85-2.52-3.20-1.70-1.01-2.31-0.44-0.20
Increase Decrease In Accounts Payable 0.75-2.980.192.120.94-0.030.240.400.18-0.710.480.200.020.07-0.980.75
Share Based Compensation 0.631.571.541.462.361.903.433.880.790.010.020.120.631.110.00-0.00

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31
Net Cash Provided By Used In Financing Activities 0.008.570.010.000.000.000.000.00-0.0346.770.000.000.00-0.0512.09-0.00

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Liabilities
Assets
Cash And Cash Equivalents At Carrying Value
Current Assets
Cash And Cash Equivalents At Carrying Value
Liabilities
Liabilities
Current Liabilities
Employee Related Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
Shares
Weighted Average Number Of Diluted Shares Outstanding

Line plots across dimensions of each concept


us-gaap:OperatingExpenses
us-gaap:Restatement
(None,)
Operating Expensesus-gaap: Restatement
us-gaap:ResearchAndDevelopmentExpense
us-gaap:Restatement
(None,)
Research And Development Expenseus-gaap: Restatement
us-gaap:OperatingIncomeLoss
us-gaap:Restatement
(None,)
Operating Income Lossus-gaap: Restatement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:ProfitLoss
us-gaap:Restatement
(None,)
Profit Lossus-gaap: Restatement
us-gaap:NetIncomeLoss
us-gaap:Restatement
(None,)
Net Income Lossus-gaap: Restatement
us-gaap:Assets
us-gaap:Restatement
(None,)
Assetsus-gaap: Restatement
us-gaap:LiabilitiesAndStockholdersEquity
us-gaap:Restatement
(None,)
Liabilities And Stockholders Equityus-gaap: Restatement
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockholdersEquity
us-gaap:Restatement
(None,)
Stockholders Equityus-gaap: Restatement
us-gaap:AssetsCurrent
us-gaap:Restatement
(None,)
Assets Currentus-gaap: Restatement
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockholdersEquity
us-gaap:Restatement
(None,)
Stockholders Equityus-gaap: Restatement
us-gaap:RetainedEarningsAccumulatedDeficit
us-gaap:Restatement
(None,)
Retained Earnings Accumulated Deficitus-gaap: Restatement
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)
Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components
us-gaap:NetIncomeLoss
us-gaap:Restatement
(None,)
Net Income Lossus-gaap: Restatement
us-gaap:ProfitLoss
us-gaap:Restatement
(None,)
Profit Lossus-gaap: Restatement
us-gaap:ShareBasedCompensation
us-gaap:IncomeStatementLocation
(None,)
Share Based Compensationus-gaap: Income Statement Location